BioSpace News Archive

Company will report financial results for the second quarter ended June 30, 2019 on Thursday, August 8, 2019 after U.S. markets close.

An accompanying conference call will be held at 8:00 am ET on July 31, 2019.

Approval advances eMacula™ system to human testing and feasibility studies

April Hansen, Executive Vice President of Workforce Solutions and Clinical Services for Aya Healthcare, the company transforming travel nurse staffing and healthcare workforce solutions across the United States, made Staffing Industry Analysts’ 2019 40 Under 40 list

The dial-in number for the conference call is (844) 413-7154 (U.S. and Canada) or (216) 562-0466 (international) and entering passcode 8268638.

As opposed to traditional static interbodies, PROLIFT was engineered to reduce the need for surgical steps, such as sequential trialing, and in turn reduce operating time.

Students graduating with internship experience are more likely to find employment upon graduating than students without it, according to research.

Milliman, Inc., a premier global consulting and actuarial firm, today released the 2019 Milliman Medical Index (MMI), which measures healthcare costs for individuals and families receiving coverage from an employer-sponsored preferred provider plan (PPO)

The first patient enrolled into this study was treated at Oxford Heart Center, Oxford, UK by Professor Adrian Banning, the principal investigator of the study.

AptarGroup, Inc. (NYSE: ATR), a global leader in dispensing and drug delivery solutions, today announced that its Unidose Powder System was recently approved by the U.S. Food and Drug Administration (FDA) for an intranasal, needle-free rescue treatment drug intended to treat severe hypoglycemia in people with diabetes.